Stephen Bloch, MD

Co-Founder and CEO

Jay Fine, PhD

Research & Development

Jeremy Myers, PhD

Senior Vice President,
Research & Development

Jennifer Gabler

Chief Financial Officer

Louis Matis, MD

Senior Advisor to CEO &
Chairman of Scientific Advisory Board

Board of Directors

Stephen Bloch, MD
Co-Founder and CEO
Alessandra Di Bacco
Venture Partner, Takeda Oncology
Denis Patrick
Vice President Emerging Science & Innovation, Managing Partner Pfizer Ventures, Head of Partnering Innovation
Ian Taylor, PhD
Chief Scientific Officer, Arvinas
Daguang Wang, PhD
Managing Director, Yonjin Venture, Board Observer
Derek Yoon
President and CEO, Solasta Ventures

Scientific Advisory

Richard Flavell, PhD
Yale – Sterling Professor, Chairman Emeritus of Immunobiology, Howard Hughes Medical Institute Investigator
Susan Kaech, PhD
Salk Institute* – Director NOMIS Center for Immunobiology and Microbial Pathogenesis, NOMIS Chair
*Participation by Dr. Kaech as a member of the Scientific Advisory Board does not constitute or imply endorsement by the Salk Institute for Biological Studies
Nils Lonberg, PhD
Executive in Residence – Canaan Partners
Former SVP Biologics Discovery, Oncology Discovery – Bristol-Myers Squibb Partnered w/ Jim Allison on CTLA-4 drug development
Mario Sznol, MD
Co-Director, Yale Cancer Immunology; Skin Cancer institute
Leader of the Melanoma/Renal Cancer Translational Team, Former president Society of Immunotherapy in Cancer (SITC)


Stephen Bloch, MD
Co-Founder and CEO
Charles Fuchs MD, MPH
Senior Vice President, Global Head Oncology and Hematology Drug Development – Genentech Roche, Former Physician-in-Chief Yale-Smilow Cancer Center
Sidi Chen, PhD
Associate Professor, Group Leader, Department of Genetics & Systems Biology Institute, Yale Cancer Systems Biology Center
Yale University

Working With The Best